U-M hosts 'The Bridge from Discovery to Medical Practice' symposium Oct. 1

U-M North Campus Research Complex Executive Director David Canter to provide keynote address on turning vision for NCRC into reality

Dr. David Canter

ANN ARBOR, Mich. - David Canter, executive director of the University of Michigan's North Campus Research Complex, will discuss turning the vision of the new campus into reality during his keynote address at the "Translational Research: The Bridge from Discovery to Medical Practice," symposium 10 a.m.-noon Oct. 1 at the U-M Health System.

The event is sponsored by the A. Alfred Taubman Medical Research Institute and the Michigan Institute for Clinical & Health Research.

As research teams from around the university begin moving into the sprawling research campus, formerly owned by Pfizer, this year's symposium is focusing on U-M's commitment to translational research, transforming laboratory discoveries into real health gains through new approaches to prevention diagnosis and the treatment of disease.

Canter will be joined by distinguished U-M faculty, who will discuss their research and the work they are doing to accelerate the pace of medical progress.

The symposium will be held in the D. Dan and Betty Kahn Auditorium, Biomedical Science Research Building, 109 Zina Pitcher Place.

Free registration continues online through September 30 at http://educationsymposium.wordpress.com/. Space is limited so register today.

David Canter
- In his new role as executive director, Canter has the responsibility for mapping, developing and implementing the university's strategy to make the most of the 28 buildings and dozens of acres of open land at the North Campus Research Complex. After nearly 25 years in pharmaceutical research and leadership at Pfizer as senior vice president of Global Research and Development, Canter became director of the Healthcare Research Initiative at the William Davidson Institute, a non-profit research and educational institute at the University of Michigan. Since 2008, he has led an effort to test business-based approaches to improving health care delivery in developing nations.

Eva L. Feldman, M.D., Ph.D

Russell N. DeJong Professor of Neurology
Director, A. Alfred Taubman Medical Research Institute

Max S. Wicha, M.D.
Professor, Department of Internal Medicine
Director, University of Michigan Comprehensive Cancer Center

Blake Roessler, M.D.
Associate Professor, Department of Internal Medicine
Associate Director, Michigan Institute for Clinical & Health Research

About the Taubman Research Institute
The mission of the A. Alfred Taubman Medical Research Institute is to provide the University of Michigan's finest medical scientists the freedom, resources and collaborative environment they need to push the boundaries of medical discovery, to produce breakthroughs in cures and treatment of disease and ultimately to alleviate human suffering.

About the Michigan Institute for Clinical & Health Research
MICHR's mission is to enable & enhance clinical & translational research. Supporting every stage of research, MICHR is moving medicine forward to improve health treatments and find cures.

NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute Michigan Medicine as the original creator and include a link to this article.

Media Inquiries:  734-764-2220 8 a.m.-5 p.m. ET 

734-936-4000 after hours, weekends, and holidays (ask for the PR person on call)  umhsmedia@umich.edu for embargoed news, videos & more